fluoxymesterone has been researched along with Disease Exacerbation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, J; Andersson, M; Bastholt, L; Christensen, IJ; Dombernowsky, P; Kamby, C; Mouridsen, HT; Munkholm, P; Møller, KA; Rose, C | 1 |
1 trial(s) available for fluoxymesterone and Disease Exacerbation
Article | Year |
---|---|
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Topics: Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Drug Synergism; Enzyme Inhibitors; Female; Fluoxymesterone; Humans; Hydrocortisone; Life Tables; Neoplasm Metastasis; Neoplasm Proteins; Salvage Therapy; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Treatment Outcome | 2000 |